Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats

Journal of NeuroVirology

Volumn 14, Issue 3, 2008, Pages 252-260

  Solbrig, Marylou V ^a   Hermanowicz, Neal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Microglia; Nneurogenesis; Parkinson's disease

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; EXPERIMENTAL INFECTION; MALE; MICROGLIA; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS ENCEPHALITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOXAZINES; BORNA DISEASE; BORNA DISEASE VIRUS; CANNABINOIDS; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; CORPUS STRIATUM; DRUG ADMINISTRATION SCHEDULE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MALE; MICROGLIA; MORPHOLINES; NAPHTHALENES; NEURONS; RATS; RATS, INBRED LEW; STEM CELLS;

BORNA DISEASE VIRUS; RATTUS;

EID: 46049116851     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280802074521     Document Type: Article

References (85)

1. Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M. and Galve-Roperh, I. (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J, 19, pp. 1704-1706.
2. Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzman, M. and Galve-Roperh, I. (2007) The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem, 282, pp. 23892-23898.
3. Anthony, I. C., Crawford, D. H. and Bell, J. E. (2004) Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brain. J NeuroVirol, 10, pp. 181-188.
4. Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P. and Bell, J. E. (2005) Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?. Neuropathol Appl Neurobiol, 31, pp. 325-338.
5. Arango, J-C, Simmonds, P., Brettle, R. P. and Bell, J. E. (2004) Does drug abuse influence the microglial response in AIDS and HIV encephalitis?. AIDS, 18, pp. S69-S74.
6. Bagri, A., Gurney, T., He, X., Zou, Y. R., Littman, D. R., Tessier-Lavigne, M. and Pleasure, S. J. (2002) The chemokine SDF1 regulates migration of dentate granule cells. Development, 129, pp. 4249-4260.
7. Bauer, J., Sminia, T., Wouterlood, F. G. and Dijkstra, C. D. (1994) Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res, 38, pp. 365-375.
8. Bautista, J. R., Schwartz, G. J., de la Torre, J. C., Moran, T. H. and Carbone, K. M. (1994) Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection. Brain Res Bull, 34, pp. 31-40.
9. Benito, C., Kim, W. K., Chavarria, I., Hillard, C. J., Mackie, K., Tolon, R. M., Williams, K. and Romero, J. (2005) A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci, 25, pp. 2530-2536.
10. Billaud, J. N., Ly, C., Philips, T. R. and de la Torre, J. C. (2000) Borna disease virus persistence causes inhibition of glutamate uptake by feline primary cortical astrocytes. J Virol, 74, pp. 10438-10446.
11. Bilzer, T. and Stitz, L. (1994) Immune-mediated brain atrophy. CD8+ T cells contribute to tissue destruction during borna disease. J Immunol, 153, pp. 818-823.
12. Carbone, K. M., Moench, T. R. and Lipkin, W. I. (1991) Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: Location of viral genomic and messenger RNAs by in situ hybridization. J Neuropathol Exp Neurol, 50, pp. 205-214.
13. Carbone, K. M., Trapp, B. D., Griffin, J. W., Duchala, C. S. and Narayan, O. (1989) Astrocytes and Schwann cells are virus-host cells in the nervous system of rats with Borna disease. J Neuropathol Exp Neurol, 48, pp. 631-644.
14. Centonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardini, G., Bernardini, S., Martino, G. and Maccarrone, M. (2007) The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain, 130, pp. 2543-2553.
15. Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B. and Grant, HNRC Group (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64, pp. 1343-1347.
16. Crews, F. T. and Nixon, K. (2003) Alcoholism, neural stem cells, and adult neurogenesis. Alcohol Res Health, 27, pp. 197-204.
17. Curtis, M. A., Faull, R. L. and Glass, M. (2006) A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain. J Chem Neuroanat, 31, pp. 210-215.
18. Czub, S., Czub, M., Koutsilieri, E., Sopper, S., Villinger, F., Muller, J. G., Stahl-Hennig, C., Riederer, P., ter Meulen, V and Gosztonyi, G. (2004) Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol, 107, pp. 216-226.
19. Dietz, D., Vogel, M., Rubin, S., Moran, T., Carbone, K. and Pletnikov, M. (2004) Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: A multidisciplinary analysis. J NeuroVirol, 10, pp. 267-277.
20. Dominguez-Escriba, L., Hernandez-Rabaza, V., Soriano-Navarro, M., Romero, F. J., Garcia-Verdugo, J. M. and Canales, J. J. (2006) Chronic cocaine exposure impairs progenitor proliferation but spares survival and maturation of neural precursors in adult rat dentate gyrus. Eur J Neurosci, 24, pp. 586-594.
21. Ehrhart, J., Obregon, D., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J. and Shytle, R. D. (2005) Stimulation of cannabinoid receptor (CB2) suppresses microglial activation. J Neuroinflamm, 2, p. 29.
22. Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W. and Nestler, E. J. (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A, 97, pp. 7579-7584.
23. Eisch, A. J. and Harburg, G. C. (2006) Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Hippocampus, 16, pp. 271-286.
24. Ekdahl, C. T., Claasen, J-H, Bonde, S., Kokaia, Z. and Lindvall, O. (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A, 100, pp. 13632-13637.
25. El-Hage, N., Wu, G., Wang, J., Ambati, J., Knapp, P. E., Reed, J. L., Bruce-Keller, A. J. and Hauser, K. F. (2006) HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia, 53, pp. 132-146.
26. Fu, Z. F., Weihe, E., Zheng, Y. M., Schafer, M. K., Sheng, H., Corisdeo, S., Rauscher 3rd, F. J., Koprowski, H. and Dietzschold, B. (1993) Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol, 67, pp. 6674-6681.
27. Garcia-Arencibia, M., Gonzalez, S., de Lago, E., Ramos, J. A., Mechoulam, R. and Fernandez-Ruiz, J. (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties. Brain Res, 1134, pp. 162-170.
28. Gavrilin, M. A., Mathes, L. E. and Podell, M. (2002) Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J NeuroVirol, 8, pp. 240-249.
29. Gonzalez-Dunia, D., Watanabe, M., Syan, S., Mallory, M., Masliah, E. and De La Torre, J. C. (2000) Synaptic pathology in Borna disease virus persistent infection. J Virol, 74, pp. 3441-3448.
30. Gosztonyi, G. and Ludwig, H. (1995) Borna disease-neuropathology and pathogenesis. Curr Top Microbiol Immunol, 190, pp. 39-73.
31. Gosztonyi, G. and Ludwig, H. (2001) Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons. Curr Top Microbiol Immunol, 253, pp. 121-144.
32. Guindon, J. and Hohmann, A. G. (2008) Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol, 153, pp. 319-334.
33. Guzman, M. and Galve-Roperh, I. (2002) Cannabinoids and cell fate. Pharmacol Ther, 95, pp. 175-184.
34. Haas, B., Becht, H. and Rott, R. (1986) Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna Disease virus. J Gen Virol, 67, pp. 235-241.
35. Hajos, N. and Freund, T. F. (2002) Pharmacological separation of cannabinoid-sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology, 43, pp. 503-510.
36. Hans, A., Bajramovic, J. J., Syan, S., Perret, E., Dunia, I., Brahic, M. and Gonzalez-Dunia, D. (2004) Persistent non-cytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF-induced synaptogenesis. FASEB J, 18, pp. 863-865.
37. Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L. A. and Mackie, K. (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci, 28, pp. 83-92.
38. Hauser, K. F., El-Hage, N., Buch, S., Berger, J. R., Tyor, W. R., Nath, A., Brude-Keller, A. J. and Knapp, P. E. (2005) Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res, 8, pp. 63-80.
39. Hornig, M., Weissenbock, H., Horscroft, N. and Lipkin, W. I. (1999) An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A, 96, pp. 12102-12107.
40. Jhaveri, M. D., Sagar, D. R., Elmes, S JR, Kendall, D. A. and Chapman, V. (2007) Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol, 36, pp. 26-35.
41. Jiang, W., Zhang, Y., Xiao, L., Van Cleemput, J., Ji, S. P., Bai, G. and Zhang, X. (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest, 115, pp. 3104-3016.
42. Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J. and Greenberg, D. A. (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol, 66, pp. 204-208.
43. Kamitani, W., Shoya, Y., Kobayashi, T., Watanabe, M., Lee, B. J., Zhang, G., Tomonaga, K. and Ikuta, K. (2001) Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1. J Virol, 75, pp. 8742-8751.
44. Kuhn, H. G., Dickinson-Anson, H. and Gage, F. H. (1996) Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor population. J Neurosci, 16, pp. 2027-2033.
45. Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., Marcotte, T. D., Masliah, E. and HNRC Group (2003) Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr, 34, pp. 467-474.
46. LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A. and Piomelli, D. (2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferators-activated receptor-alpha. J Pharmacol Exp Ther, 319, pp. 1051-1061.
47. Lu, M., Grove, E. A. and Miller, R. J. (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci U S A, 99, pp. 7090-7095.
48. Mackie, K. and Stella, N. (2006) Cannabinoid receptors and endocannabinoids: Evidence for new players. AAPS J, 8, pp. E298-E306.
49. Mayer, D., Fisher, H., Schneider, U., Heimrich, B. and Schwemmle, M. (2005) Borna disease virus replication in organotypic hippocampal slice cultures from rats results in selective damage of dentate granule cells. J Virol, 79, pp. 11716-11723.
50. McCoy, K. L., Gainey, D. and Cabral, G. A. (1995) Delta 9-tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther, 273, pp. 1216-1223.
51. McCoy, K. L., Matveyeva, M., Carlisle, S. J. and Cabral, G. A. (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: Evidence for CB2 receptor participation. J Pharmacol Exp Ther, 289, pp. 1620-1625.
52. Mechoulam, R., Panikashvili, D. and Shohami, E. (2002) Cannabinoids and brain injury: Therapeutic implications. Trends Mol Med, 8, pp. 58-61.
53. Miller, A. M. and Stella, N. (2008) CB2 receptor-mediated migration of immune cells: It can go either way. Br J Pharmacol, 158, pp. 299-308.
54. Molina, P. E., McNurlan, M., Rathmacher, J., Lang, C. H., Zambell, K. L., Purcell, J., Bohm, R. P., Zhang, P., Bagby, G. J. and Nelson, S. (2006) Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res, 30, pp. 2065-2078.
55. Monje, M. L., Toda, H. and Palmer, T. D. (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science, 302, pp. 1760-1765.
56. Morgese, M. G., Cassano, T., Cuomo, V. and Giuffrida, A. (2007) Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptors. Exp Neurol, 208, pp. 110-119.
57. Narayan, O., Herzog, S., Frese, K., Scheefers, H. and Rott, R. (1983) Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science, 220, pp. 1401-1403.
58. Nilsson, O., Fowler, C. J. and Jacobsson, S. O. (2006) The cannabinoid agonist WIN 55212-2 inhibits TNF alpha-induced neutrophil transmigration across ECV304 cells. Eur J Pharmacol, 547, pp. 165-173.
59. Paxinos, G. and Watson, C. (1998) The rat brain in stereotaxic coordinates,, Academic Press, San Diego
60. Perez-Casanova, A., Noel Jr, R. J., Rivera-Amill, V., Husain, K. and Kumar, A. (2007) Morphine-mediated deterioration of oxidative stress leads to rapid disease progression in SIV/SHIV-infected macaques. AIDS Res Hum Retroviruses, 23, pp. 1004-1007.
61. Planz, O. and Stitz, L. (1999) Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response. J Virol, 73, pp. 1715-1718.
62. Pletnikov, M. V., Moran, T. H. and Carbone, K. M. (2002) Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders. Front Biosci, 7, p. d593.
63. Pryce, G., Ahmed, Z., Hankey, D JR, Jackson, S. J., Corxford, J. L., Pocock, J. M., Ledent, C., Petzold, A., Thompson, A. J., Giovannoni, G., Cuzner, M. L. and Baker, D. (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain, 126, pp. 2191-2202.
64. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., Wolfson, T. and Grant, HNRC Group (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc, 10, pp. 1-14.
65. Sagredo, O., Garcia-Arencibia, M., de Lago, E., Finetti, S., Decio, A. and Fernandez-Ruiz, J. (2007) Cannabinoids and neuroprotection in basal ganglia disorders. Mol Neurobiol, 36, pp. 82-91.
66. Sanchez, A. J., Gonzalez-Perez, P., Galve-Roperh, I. and Garcia-Merino, A. (2006) R-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo- [1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2)ameliorates experimental autoimmuneencephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB(2) receptor. Biochem Pharmacol 72: 1697-1706.
67. Sasaki, S. and Ludwig, H. (1993) In borna disease virus infected rabbit neurons 100 nm particle structures accumulate at areas of Joest-Degen inclusion bodies. Zentralbl Veterinarmed B, 40, pp. 291-297.
68. Solbrig, M. V., Adrian, R., Baratta, J., Lauterborne, J. and Koob, G. F. (2006) Kappa opioid control of seizures by a virus in an animal model. Brain, 129, pp. 642-654.
69. Solbrig, M. V., Adrian, R., Baratta, J., Piomelli, D. and Giuffrida, A. (2005) Role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Exp Neurol, 194, pp. 355-362.
70. Solbrig, M. V. and Koob, G. F. (2003) Neuropharmacological sequelae of Borna Disease Virus. Pharmacol Biochem Behav, 74, pp. 777-787.
71. Solbrig, M. V., Koob, G. F., Fallon, J. H. and Lipkin, W. I. (1994) Tardive dyskinetic syndrome in rats infected with Borna disease virus. Neurobiol Dis, 1, pp. 111-119.
72. Solbrig, M. V., Koob, G. F. and Lipkin, W. I. (1998) Cocaine sensitivity in Borna disease virus-infected rats. Pharmacol Biochem Behavior, 59, pp. 1047-1052.
73. Solbrig, M. V., Koob, G. F. and Lipkin, W. I. (2002) Key role for enkephalinergic tone in cortico-striatal-thalamic function. Eur J Neurosci, 16, pp. 1819-1822.
74. Solbrig, M. V., Koob, G. F., Parsons, L. H., Horscroft, N., Kadota, T., Briese, T. and Lipkin, W. I. (2000) Neurotrophic factor expression following CNS viral injury produces enhanced sensitivity to psychostimulants: Potential mechanism for addiction vulnerability. J Neurosci, 20, pp. 1-6.
75. Solbrig, M. V., Schlaberg, R., Briese, T., Horscroft, N. and Lipkin, W. I. (2002) Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats. Antimicrob Agents Chemother, 46, pp. 2287-2291.
76. Stitz, L., Bilzer, T. and Planz, O. (2002) The immunopathogenesis of Borna disease virus infection. Front Biosci, 7, p. d541.
77. Stumm, R. K., Zhou, C., Ara, T., Lazarini, F., Dubois-Dalcq, M., Nagasawa, T., Hollt, V. and Schulz, S. (2003) CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci, 23, pp. 5123-5130.
78. Venkatesan, A., Nath, A., Ming, G. L. and Song, H. (2007) Adult hippocampal neurogenesis: Regulation by HIV and drugs of abuse. Cell Mol Life Sci, 64, pp. 2120-2132.
79. Wahner, A. D., Bronstein, J. M., Bordelon, Y. M. and Ritz, B. (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology, 69, pp. 1836-1842.
80. Walter, L. and Stella, N. (2004) Cannabinoids and neuroinflammation. Br J Pharmacol, 141, pp. 775-785.
81. Welch, S. P., Huffman, J. W. and Lowe, J. (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J Pharmacol Exp Ther, 286, pp. 1301-1308.
82. Williams, B. L., Hornig, M., Yaddanapudi, K. and Lipkin, W. I. (2008) Hippocampal PARP-1 and caspase-3 activation in neonatal Bornavirus infection. J Virol, 82, pp. 1748-1758.
83. Williams, B. L., Yaddanapudi, K., Kirk, C. M., Soman, A., Hornig, M. and Lipkin, W. I. (2006) Metallothioneins and zinc dysregulation contribute to neurodevelopmental damage in a model of perinatal viral infection. Brain Pathol, 16, pp. 1-14.
84. Witting, A., Chen, L., Cudaback, E., Straiker, A., Walter, L., Rickman, B., Moller, T., Brosnan, C. and Stella, N. (2006) Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci U S A, 103, pp. 6362-6367.
85. Yamaguchi, M., Suzuki, T., Seki, T., Namba, T., Juan, R., Arai, H., Hori, T. and Asada, T. (2004) Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann N Y Acad Sci, 1025, pp. 351-362.